Blue Earth Therapeutics is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat cancer patients. With proven leadership and therapeutic radiopharmaceutical expertise, Blue Earth Therapeutics has a strong pipeline of precision targeted radiopharmaceuticals. Their initial focus is on prostate cancer, with plans to expand to additional disease areas within cancer care.
The approach of Blue Earth Therapeutics is to build on the progress seen with first generation radiopharmaceuticals with unique, targeted radio hybrid agents.
PP-UK-0656 / October 2023